Amino Acid/Electrolyte Mixture-based Dietary Supplement clinical trials
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2016
How each study uses Amino Acid/Electrolyte Mixture-based Dietary Supplement is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Enterade
- 5
Studies by the year they started
5 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 5
Dana-Farber Cancer Institute (1) · Lowell Anthony, MD (1) · Virginia Commonwealth University (1) · Vanderbilt-Ingram Cancer Center (1) · PATH (1)
Studies
Open first, then newest update. How each study uses Amino Acid/Electrolyte Mixture-based Dietary Supplement is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin LymphomaCompletedNot applicableDana-Farber Cancer InstituteNCT02919670Written as Enterade
- Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETsCompletedPhase 2Lowell Anthony, MDNCT03722511Written as Amino Acid Based Medical Food/Drink
- Acceptability and Efficacy of Enterade (VS001) in Children at Risk for Environmental Enteric Dysfunction in BangladeshCompletedNot applicableVirginia Commonwealth UniversityNCT05291559Written as Enterade
- Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel FrequencyTerminatedNot applicableVanderbilt-Ingram Cancer CenterNCT04073017Written as Enterade®
- Safety, Acceptability, and Feasibility of Enterade®TerminatedNot applicablePATHNCT03782272Written as Enterade